Results summary | View all lists in GO:BiolProc | View all genes in D07AC.profile.d50 |
The specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. enrichment: 2.81-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
204998_S_AT | ATF5 | G | R | activating transcription factor 5 | |||||||||
205486_AT | TESK2 | G | P | C | S | testis-specific kinase 2 | |||||||
211851_X_AT | BRCA1 | G | X | E | P | R | S | breast cancer 1, early onset | |||||
219072_AT | BCL7C | G | B-cell CLL/lymphoma 7C | ||||||||||
205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
222164_AT | FGFR1 | G | D | P | C | S | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | ||||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 |